mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for TAF1
Gene summary
Basic gene Info.Gene symbolTAF1
Gene nameTAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa
SynonymsBA2R|CCG1|CCGS|DYT3|DYT3/TAF1|KAT4|N-TAF1|NSCL2|OF|P250|TAF(II)250|TAF2A|TAFII-250|TAFII250|XDP
CytomapUCSC genome browser: Xq13.1
Type of geneprotein-coding
RefGenesNM_001286074.1,
NM_004606.4,NM_138923.3,NR_104387.1,NR_104388.1,
NR_104389.1,NR_104390.1,NR_104391.1,NR_104392.1,
NR_104393.1,NR_104394.1,NR_104395.1,NR_104396.1,
DescriptionTBP-associated factor 250 kDacell cycle gene 1 proteincell cycle, G1 phase defectcomplementation of cell cycle block, G1-to-Stranscription factor TFIID p250 polypeptidetranscription initiation factor TFIID subunit 1
Modification date20141219
dbXrefs MIM : 313650
HGNC : HGNC
Ensembl : ENSG00000147133
HPRD : 02436
Vega : OTTHUMG00000022723
ProteinUniProt: P21675
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_TAF1
BioGPS: 6872
PathwayNCI Pathway Interaction Database: TAF1
KEGG: TAF1
REACTOME: TAF1
Pathway Commons: TAF1
ContextiHOP: TAF1
ligand binding site mutation search in PubMed: TAF1
UCL Cancer Institute: TAF1
Assigned class in mutLBSgeneDBB: This gene belongs to targetable_mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0016573histone acetylation8980232
GO:0018105peptidyl-serine phosphorylation8625415
GO:0018107peptidyl-threonine phosphorylation15053879
GO:0032436positive regulation of proteasomal ubiquitin-dependent protein catabolic process15053879
GO:0045944positive regulation of transcription from RNA polymerase II promoter17996705
GO:0046777protein autophosphorylation8625415


Top
Ligand binding site mutations for TAF1
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
Y1589S1587RLUSC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for TAF1
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
Y1589S1587R-0.649918
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for TAF1 from PDB

Top
Differential gene expression and gene-gene network for TAF1
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of TAF1 and the right PPI network was created from samples without mutations in the LBS of TAF1. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for TAF1
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C1839130Dystonia 3, Torsion, X-Linked14Biomarker, GeneticVariation

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for TAF1
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of TAF1 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
IIIPeptide ligand (LYS,GLY,GLY,LYS,GLY,LEU,GLY)4yymAY1589
IIIPeptide ligand (LYS,GLY,GLY,LYS,GLY,LEU,GLY)4yymBY1589
IIIPeptide ligand (SER,GLY,ARG,GLY,LYS,GLY,GLY,LYS,GLY,LEU,GLY)4yynAY1589
IIIPeptide ligand (SER,GLY,ARG,GLY,LYS,GLY,GLY,LYS,GLY,LEU,GLY)4yynBY1589


Top
Conservation information for LBS of TAF1
Multiple alignments for P21675 in multiple species
LBSAA sequence# speciesSpecies
D1524MMAVPDSWPFH1Homo sapiens
D1524MKNIPKSALFH1Caenorhabditis elegans
D1524IKQLPESWPFL1Drosophila melanogaster
D1539KKFVPDYYKVI1Homo sapiens
D1539PKKIPAYYLKI1Caenorhabditis elegans
D1539KKQVKDYYTVI1Drosophila melanogaster
F1528PDSWPFHHPVN1Homo sapiens
F1528PKSALFHTRVD1Caenorhabditis elegans
F1528PESWPFLKPVN1Drosophila melanogaster
F1536PVNKKFVPDYY1Homo sapiens
F1536RVDPKKIPAYY1Caenorhabditis elegans
F1536PVNKKQVKDYY1Drosophila melanogaster
G1584SVKYNGPESQY1Homo sapiens
G1584SVVFNGAESVY1Caenorhabditis elegans
G1584CEQYNGSDTRY1Drosophila melanogaster
H1530SWPFHHPVNKK1Homo sapiens
H1530SALFHTRVDPK1Caenorhabditis elegans
H1530SWPFLKPVNKK1Drosophila melanogaster
K1542VPDYYKVIVNP1Homo sapiens
K1542IPAYYLKISDP1Caenorhabditis elegans
K1542VKDYYTVIKRP1Drosophila melanogaster
K1581LANSVKYNGPE1Homo sapiens
K1581YTNSVVFNGAE1Caenorhabditis elegans
K1581ATNCEQYNGSD1Drosophila melanogaster
M1548VIVNPMDLETI1Homo sapiens
M1548KISDPMDLSIM1Caenorhabditis elegans
M1548VIKRPMDLETI1Drosophila melanogaster
N1583NSVKYNGPESQ1Homo sapiens
N1583NSVVFNGAESV1Caenorhabditis elegans
N1583NCEQYNGSDTR1Drosophila melanogaster
P1527VPDSWPFHHPV1Homo sapiens
P1527IPKSALFHTRV1Caenorhabditis elegans
P1527LPESWPFLKPV1Drosophila melanogaster
V1532PFHHPVNKKFV1Homo sapiens
V1532LFHTRVDPKKI1Caenorhabditis elegans
V1532PFLKPVNKKQV1Drosophila melanogaster
V1537VNKKFVPDYYK1Homo sapiens
V1537VDPKKIPAYYL1Caenorhabditis elegans
V1537VNKKQVKDYYT1Drosophila melanogaster
W1526AVPDSWPFHHP1Homo sapiens
W1526NIPKSALFHTR1Caenorhabditis elegans
W1526QLPESWPFLKP1Drosophila melanogaster
Y1540KFVPDYYKVIV1Homo sapiens
Y1540KKIPAYYLKIS1Caenorhabditis elegans
Y1540KQVKDYYTVIK1Drosophila melanogaster
Y1582ANSVKYNGPES1Homo sapiens
Y1582TNSVVFNGAES1Caenorhabditis elegans
Y1582TNCEQYNGSDT1Drosophila melanogaster
Y1589GPESQYTKTAQ1Homo sapiens
Y1589GAESVYSLKAK1Caenorhabditis elegans
Y1589GSDTRYTKFSK1Drosophila melanogaster


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas